Bluejay Diagnostics, Inc. Common Stock
Market Cap
1.1M
Short interest (Jul 15)
55.1%
Net Short (Jul 27 ): -0.1%
Borrow Fee
490.85%
↓ 32.4%
Available Shares
200K
↑ 8934.1%
Price Chart
Company Overview
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.